Beacon Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 2, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	26,403	24,463	35,528	56,595	59,667	28,552
Market Cap Growth	2.05%	-31.14%	-37.22%	-5.15%	108.98%	103.62%
Enterprise Value	35,443	30,968	45,350	62,791	63,025	30,523
Last Close Price	114.30	103.72	148.05	234.30	245.53	116.74
PE Ratio	18.12	25.85	68.19	111.01	63.81	33.08
PS Ratio	1.70	1.95	3.32	6.65	7.44	4.01
PB Ratio	3.41	3.67	5.83	9.53	10.04	5.33
P/TBV Ratio	3.41	3.68	5.86	9.54	10.04	5.33
P/FCF Ratio	17.65	31.42	-	-	-	-
P/OCF Ratio	10.46	15.29	-	91.11	55.14	145.26
EV/Sales Ratio	2.28	2.47	4.24	7.38	7.86	4.29
EV/EBITDA Ratio	9.65	10.44	19.36	41.92	30.64	17.47
EV/EBIT Ratio	11.50	13.27	24.99	64.13	38.97	22.42
EV/FCF Ratio	23.70	39.78	-	-	-	-
Debt / Equity Ratio	1.22	1.53	1.69	1.25	0.64	0.47
Debt / EBITDA Ratio	2.57	3.44	4.41	4.98	1.86	1.43
Debt / FCF Ratio	6.32	13.11	-	-	-	-
Net Debt / Equity Ratio	1.17	1.49	1.64	1.17	0.55	0.40
Net Debt / EBITDA Ratio	2.48	3.36	4.27	4.66	1.60	1.23
Net Debt / FCF Ratio	6.04	12.80	-7.84	-5.85	-5.15	-18.43
Asset Turnover	-	0.65	0.64	0.67	0.83	0.91
Inventory Turnover	-	1.96	2.14	2.15	2.40	2.99
Quick Ratio	0.46	0.39	0.36	0.36	0.54	0.82
Current Ratio	1.61	1.54	1.37	1.20	1.38	1.87
Return on Equity (ROE)	-	14.84%	8.66%	8.58%	16.55%	17.29%
Return on Assets (ROA)	-	7.61%	6.76%	4.81%	10.45%	10.83%
Return on Invested Capital (ROIC)	14.39%	10.38%	6.84%	6.64%	13.98%	14.31%
Return on Capital Employed (ROCE)	25.70%	21.10%	18.80%	13.70%	26.30%	23.70%
Earnings Yield	5.52%	3.87%	1.47%	0.90%	1.57%	3.02%
FCF Yield	5.66%	3.18%	-3.59%	-2.11%	-1.07%	-0.41%
Dividend Yield	1.83%	2.02%	1.35%	0.68%	0.65%	1.29%
Payout Ratio	18.46%	36.67%	70.93%	72.78%	39.95%	6.88%
Total Shareholder Return	1.89%	2.02%	1.35%	0.68%	0.65%	1.29%